In the current work, we have observed similar changes in the tumor microenvironment with increased scores for CD8+ and CD4+ lymphocyte functions, as well as for antigen-presenting cells such as dendritic cells, which were further enhanced in mice with pre-existing anti-HSV-1 immunity. This evidence concerns the gene CD4 and neoplasm.